Published in Toxicol Appl Pharmacol on March 12, 2007
Intellectual function in Mexican children living in a mining area and environmentally exposed to manganese. Environ Health Perspect (2010) 1.80
Role of manganese in neurodegenerative diseases. J Trace Elem Med Biol (2011) 1.73
Syndrome of hepatic cirrhosis, dystonia, polycythemia, and hypermanganesemia caused by mutations in SLC30A10, a manganese transporter in man. Am J Hum Genet (2012) 1.64
Manganese and its role in Parkinson's disease: from transport to neuropathology. Neuromolecular Med (2009) 1.54
Copper transport to the brain by the blood-brain barrier and blood-CSF barrier. Brain Res (2008) 1.36
Increased APLP1 expression and neurodegeneration in the frontal cortex of manganese-exposed non-human primates. J Neurochem (2008) 1.30
Manganese-enhanced MRI: an exceptional tool in translational neuroimaging. Schizophr Bull (2008) 1.30
Features of microglia and neuroinflammation relevant to environmental exposure and neurotoxicity. Int J Environ Res Public Health (2011) 1.27
Oxidative damage and neurodegeneration in manganese-induced neurotoxicity. Toxicol Appl Pharmacol (2009) 1.23
Ferroportin is a manganese-responsive protein that decreases manganese cytotoxicity and accumulation. J Neurochem (2009) 1.23
Manganese neurotoxicity: lessons learned from longitudinal studies in nonhuman primates. Environ Health Perspect (2008) 1.19
Basal ganglia intensity indices and diffusion weighted imaging in manganese-exposed welders. Occup Environ Med (2012) 1.17
In vivo measurement of brain GABA concentrations by magnetic resonance spectroscopy in smelters occupationally exposed to manganese. Environ Health Perspect (2010) 1.16
Metal ion acquisition in Staphylococcus aureus: overcoming nutritional immunity. Semin Immunopathol (2011) 1.13
Manganese exposure among smelting workers: blood manganese-iron ratio as a novel tool for manganese exposure assessment. Biomarkers (2009) 1.11
Chelation therapy of manganese intoxication with para-aminosalicylic acid (PAS) in Sprague-Dawley rats. Neurotoxicology (2008) 1.09
Mechanisms of lead and manganese neurotoxicity. Toxicol Res (Camb) (2013) 1.09
Biomarkers of manganese intoxication. Neurotoxicology (2010) 1.09
Cerebrospinal fluid to brain transport of manganese in a non-human primate revealed by MRI. Brain Res (2008) 1.07
Metals, oxidative stress and neurodegeneration: a focus on iron, manganese and mercury. Neurochem Int (2012) 0.99
Acquired hepatocerebral degeneration. J Neurol (2009) 0.98
Manganese Toxicity Upon Overexposure: a Decade in Review. Curr Environ Health Rep (2015) 0.97
Manganese accumulates primarily in nuclei of cultured brain cells. Neurotoxicology (2008) 0.94
Synergistic dopaminergic neurotoxicity of manganese and lipopolysaccharide: differential involvement of microglia and astroglia. J Neurochem (2009) 0.92
Microglia enhance manganese chloride-induced dopaminergic neurodegeneration: role of free radical generation. Exp Neurol (2009) 0.92
The impact of environmental metals in young urbanites' brains. Exp Toxicol Pathol (2012) 0.91
Altered manganese homeostasis and manganese toxicity in a Huntington's disease striatal cell model are not explained by defects in the iron transport system. Toxicol Sci (2010) 0.91
Drugs, biogenic amine targets and the developing brain. Dev Neurosci (2009) 0.90
Manganese neurotoxicity and the role of reactive oxygen species. Free Radic Biol Med (2013) 0.90
Apoptosis Induced by Manganese on Neuronal SK-N-MC Cell Line: Endoplasmic Reticulum (ER) Stress and Mitochondria Dysfunction. Environ Health Toxicol (2011) 0.90
Manganese-enhanced magnetic resonance imaging (MEMRI). Methods Mol Biol (2011) 0.89
Manganese neurotoxicity: a focus on glutamate transporters. Ann Occup Environ Med (2013) 0.89
Gender and manganese exposure interactions on mouse striatal neuron morphology. Neurotoxicology (2011) 0.88
Prolactin is a peripheral marker of manganese neurotoxicity. Brain Res (2011) 0.87
Novel high-throughput assay to assess cellular manganese levels in a striatal cell line model of Huntington's disease confirms a deficit in manganese accumulation. Neurotoxicology (2011) 0.87
HPLC analysis of para-aminosalicylic acid and its metabolite in plasma, cerebrospinal fluid and brain tissues. J Pharm Biomed Anal (2010) 0.87
Impact of manganese on and transfer across blood-brain and blood-cerebrospinal fluid barrier in vitro. J Biol Chem (2012) 0.87
Hippocampal neuronal metal ion imbalance related oxidative stress in a rat model of chronic aluminum exposure and neuroprotection of meloxicam. Behav Brain Funct (2014) 0.86
Manganese accumulates within golgi apparatus in dopaminergic cells as revealed by synchrotron X-ray fluorescence nanoimaging. ACS Chem Neurosci (2009) 0.86
A possible neuroprotective action of a vinylic telluride against Mn-induced neurotoxicity. Toxicol Sci (2010) 0.86
"Manganese-induced neurotoxicity: a review of its behavioral consequences and neuroprotective strategies". BMC Pharmacol Toxicol (2016) 0.86
In vivo manganese exposure modulates Erk, Akt and Darpp-32 in the striatum of developing rats, and impairs their motor function. PLoS One (2012) 0.86
Manganese-Induced Parkinsonism and Parkinson's Disease: Shared and Distinguishable Features. Int J Environ Res Public Health (2015) 0.86
The role of autophagy dysregulation in manganese-induced dopaminergic neurodegeneration. Neurotox Res (2013) 0.85
X-ray fluorescence imaging: a new tool for studying manganese neurotoxicity. PLoS One (2012) 0.84
Cellular fura-2 manganese extraction assay (CFMEA). Curr Protoc Toxicol (2011) 0.84
Relationship between changes in brain MRI and (1)H-MRS, severity of chronic liver damage, and recovery after liver transplantation. Exp Biol Med (Maywood) (2009) 0.84
β-Cell subcellular localization of glucose-stimulated Mn uptake by X-ray fluorescence microscopy: implications for pancreatic MRI. Contrast Media Mol Imaging (2011) 0.84
An analysis of the effects of Mn2+ on oxidative phosphorylation in liver, brain, and heart mitochondria using state 3 oxidation rate assays. Toxicol Appl Pharmacol (2010) 0.83
Manganese accumulation in bone following chronic exposure in rats: steady-state concentration and half-life in bone. Toxicol Lett (2014) 0.83
α-Synuclein, leucine-rich repeat kinase-2, and manganese in the pathogenesis of Parkinson disease. Neurotoxicology (2011) 0.83
Cellular manganese content is developmentally regulated in human dopaminergic neurons. Sci Rep (2014) 0.82
Genome-Wide Analyses of Metal Responsive Genes in Caenorhabditis elegans. Front Genet (2012) 0.82
Incorporating genetics and genomics in risk assessment for inhaled manganese: from data to policy. Neurotoxicology (2009) 0.82
Environmental exposure, obesity, and Parkinson's disease: lessons from fat and old worms. Environ Health Perspect (2010) 0.82
Insights from Caenorhabditis elegans on the role of metals in neurodegenerative diseases. Metallomics (2011) 0.82
Subacute manganese exposure in rats is a neurochemical model of early manganese toxicity. Neurotoxicology (2014) 0.81
Relative contribution of CTR1 and DMT1 in copper transport by the blood-CSF barrier: implication in manganese-induced neurotoxicity. Toxicol Appl Pharmacol (2012) 0.81
Manganese potentiates LPS-induced heme-oxygenase 1 in microglia but not dopaminergic cells: role in controlling microglial hydrogen peroxide and inflammatory cytokine output. Neurotoxicology (2011) 0.81
Vanadium exposure induces olfactory dysfunction in an animal model of metal neurotoxicity. Neurotoxicology (2013) 0.81
Changes in the striatal proteome of YAC128Q mice exhibit gene-environment interactions between mutant huntingtin and manganese. J Proteome Res (2012) 0.80
X-ray fluorescence imaging of the hippocampal formation after manganese exposure. Metallomics (2013) 0.80
Ultrasonic disruption of the blood-brain barrier enables in vivo functional mapping of the mouse barrel field cortex with manganese-enhanced MRI. Neuroimage (2010) 0.80
Manganese modulation of MAPK pathways: effects on upstream mitogen activated protein kinase kinases and mitogen activated kinase phosphatase-1 in microglial cells. J Appl Toxicol (2011) 0.80
Chronic exposure to manganese alters brain responses to amphetamine: a pharmacological magnetic resonance imaging study. Toxicol Sci (2010) 0.80
Liver δ-aminolevulinate dehydratase activity is inhibited by neonicotinoids and restored by antioxidant agents. Int J Environ Res Public Health (2014) 0.80
BDNF and Huntingtin protein modifications by manganese: implications for striatal medium spiny neuron pathology in manganese neurotoxicity. J Neurochem (2014) 0.79
Optimization of fluorescence assay of cellular manganese status for high throughput screening. J Biochem Mol Toxicol (2012) 0.79
Manganese alters rat brain amino acids levels. Biol Trace Elem Res (2012) 0.79
Brain regional pharmacokinetics of p-aminosalicylic acid and its N-acetylated metabolite: effectiveness in chelating brain manganese. Drug Metab Dispos (2011) 0.79
Ferroportin deficiency impairs manganese metabolism in flatiron mice. FASEB J (2015) 0.79
The Caenorhabiditis elegans model as a reliable tool in neurotoxicology. Hum Exp Toxicol (2010) 0.79
Analysis of manganese-regulated gene expression in the ligninolytic basidiomycete Ceriporiopsis subvermispora. Curr Genet (2008) 0.78
Tumor-targeting novel manganese complex induces ROS-mediated apoptotic and autophagic cancer cell death. Int J Mol Med (2015) 0.78
Measuring the impact of manganese exposure on children's neurodevelopment: advances and research gaps in biomarker-based approaches. Environ Health (2016) 0.78
Roles of P-glycoprotein and multidrug resistance protein in transporting para-aminosalicylic acid and its N-acetylated metabolite in mice brain. Acta Pharmacol Sin (2014) 0.77
Pallidal index as biomarker of manganese brain accumulation and associated with manganese levels in blood: a meta-analysis. PLoS One (2014) 0.77
Using exposure windows to explore an elusive biomarker: blood manganese. Int Arch Occup Environ Health (2015) 0.77
Olfactory ferric and ferrous iron absorption in iron-deficient rats. Am J Physiol Lung Cell Mol Physiol (2012) 0.77
Functional neuroimaging using ultrasonic blood-brain barrier disruption and manganese-enhanced MRI. J Vis Exp (2012) 0.77
Manganese-induced atypical parkinsonism is associated with altered Basal Ganglia activity and changes in tissue levels of monoamines in the rat. PLoS One (2014) 0.77
Effect of manganese chloride on the neurochemical profile of the rat hypothalamus. J Cereb Blood Flow Metab (2011) 0.76
Mechanisms of divalent metal toxicity in affective disorders. Toxicology (2015) 0.76
Distribution of microfossils within polymetallic nodules: biogenic clusters within manganese layers. Mar Biotechnol (NY) (2011) 0.75
Preclinical Magnetic Resonance Imaging and Spectroscopy Studies of Memory, Aging, and Cognitive Decline. Front Aging Neurosci (2016) 0.75
Cross-sectional study of expression of divalent metal transporter-1, transferrin, and hepcidin in blood of smelters who are occupationally exposed to manganese. PeerJ (2016) 0.75
Manganese Fractionation Using a Sequential Extraction Method to Evaluate Welders' Shielded Metal Arc Welding Exposures During Construction Projects in Oil Refineries. J Occup Environ Hyg (2015) 0.75
Dietary intake of manganese and the risk of the metabolic syndrome in a Chinese population. Br J Nutr (2016) 0.75
Exposure to Mixtures of Metals and Neurodevelopmental Outcomes: A Multidisciplinary Review Using an Adverse Outcome Pathway Framework. Risk Anal (2015) 0.75
Manganese inhalation as a Parkinson disease model. Parkinsons Dis (2010) 0.75
Potential Role of Epigenetic Mechanism in Manganese Induced Neurotoxicity. Biomed Res Int (2016) 0.75
Drosophila melanogaster - an embryonic model for studying behavioral and biochemical effects of manganese exposure. EXCLI J (2014) 0.75
A compact DD neutron generator-based NAA system to quantify manganese (Mn) in bone in vivo. Physiol Meas (2014) 0.75
Cytotoxic, genotoxic, and neurotoxic effects of Mg, Pb, and Fe on pheochromocytoma (PC-12) cells. Environ Toxicol (2014) 0.75
Postnatal manganese exposure does not alter dopamine autoreceptor sensitivity in adult and adolescent male rats. Eur J Pharmacol (2013) 0.75
Expression of RNAs Coding for Metal Transporters in Blood of Patients with Huntington's Disease. Neurochem Res (2015) 0.75
Use of X-ray absorption spectroscopy to speciate manganese in airborne particulate matter from five counties across the United States. Environ Sci Technol (2012) 0.75
p73 gene in dopaminergic neurons is highly susceptible to manganese neurotoxicity. Neurotoxicology (2016) 0.75
Hair Manganese as an Exposure Biomarker among Welders. Ann Occup Hyg (2015) 0.75
Spatial learning and memory impairments are associated with increased neuronal activity in 5XFAD mouse as measured by manganese-enhanced magnetic resonance imaging. Oncotarget (2016) 0.75
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature (1998) 72.56
Rapid gene mapping in Caenorhabditis elegans using a high density polymorphism map. Nat Genet (2001) 9.54
DNA transformation. Methods Cell Biol (1995) 9.27
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci (1973) 7.85
Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science (2000) 6.28
Large-scale analysis of gene function in Caenorhabditis elegans by high-throughput RNAi. Curr Biol (2001) 6.05
Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat Genet (1997) 5.34
Welding-related parkinsonism: clinical features, treatment, and pathophysiology. Neurology (2001) 4.74
Neurobiology of the Caenorhabditis elegans genome. Science (1998) 4.34
Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport. Proc Natl Acad Sci U S A (1998) 4.07
Levodopa failure in chronic manganism. Neurology (1994) 3.80
Transferrin receptor on endothelium of brain capillaries. Nature (1984) 3.37
Manganism and idiopathic parkinsonism: similarities and differences. Neurology (1994) 3.34
Manganese toxicity upon overexposure. NMR Biomed (2004) 2.61
Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain (1991) 2.52
Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Ann Neurol (1990) 2.45
Prevalence of parkinsonism and relationship to exposure in a large sample of Alabama welders. Neurology (2005) 2.41
The SLC39 family of metal ion transporters. Pflugers Arch (2003) 2.27
Manganese-induced parkinsonism and Parkinson's disease. Ann N Y Acad Sci (2004) 2.25
Emerging themes in manganese transport, biochemistry and pathogenesis in bacteria. FEMS Microbiol Rev (2003) 2.02
Manganese neurotoxicity: a review of clinical features, imaging and pathology. Neurotoxicology (1999) 1.97
Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes. Neurology (2003) 1.89
Manganese inhibits mitochondrial aconitase: a mechanism of manganese neurotoxicity. Brain Res (1998) 1.84
Manganese dosimetry: species differences and implications for neurotoxicity. Crit Rev Toxicol (2005) 1.83
Occupational exposures to metals as risk factors for Parkinson's disease. Neurology (1997) 1.78
Positron emission tomography in manganese intoxication. Ann Neurol (1989) 1.78
ZIP8, member of the solute-carrier-39 (SLC39) metal-transporter family: characterization of transporter properties. Mol Pharmacol (2006) 1.76
Neurologic manifestations in welders with pallidal MRI T1 hyperintensity. Neurology (2005) 1.75
DMT1: a mammalian transporter for multiple metals. Biometals (2003) 1.75
Manganese exposure: neuropsychological and neurological symptoms and effects in welders. Neurotoxicology (2005) 1.71
Chronic manganese poisoning. Clinical picture and manganese turnover. Neurology (1967) 1.71
Selective increase of iron in substantia nigra zona compacta of parkinsonian brains. J Neurochem (1991) 1.70
Alteration of iron homeostasis following chronic exposure to manganese in rats. Brain Res (1999) 1.68
EXPERIMENTAL MANGANESE ENCEPHALOPATHY IN MONKEYS. A PRELIMINARY REPORT. J Neuropathol Exp Neurol (1963) 1.67
Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions. J Neurochem (1995) 1.65
Epidemiological survey among workers exposed to manganese: effects on lung, central nervous system, and some biological indices. Am J Ind Med (1987) 1.63
The regional distribution and cellular localization of iron in the rat brain. Neuroscience (1984) 1.62
Manganese intoxication during total parenteral nutrition. Lancet (1992) 1.60
Manganese intoxication in the rhesus monkey: a clinical, imaging, pathologic, and biochemical study. Neurology (1996) 1.60
Nigrostriatal dopamine system dysfunction and subtle motor deficits in manganese-exposed non-human primates. Exp Neurol (2006) 1.59
Manganese neurotoxicity, a continuum of dysfunction: results from a community based study. Neurotoxicology (1999) 1.59
Long-term exposure to "low levels" of manganese oxides and neurofunctional changes in ferroalloy workers. Neurotoxicology (1999) 1.56
Oxidative mechanisms in nigral cell death in Parkinson's disease. Mov Disord (1998) 1.55
Manganese and extrapyramidal disorders (a critical review and tribute to Dr. George C. Cotzias). Neurotoxicology (1984) 1.55
Assessment of the permissible exposure level to manganese in workers exposed to manganese dioxide dust. Br J Ind Med (1992) 1.54
Manganese encephalopathy: utility of early magnetic resonance imaging. Br J Ind Med (1993) 1.53
Chronic manganese poisoning: a neuropathological study with determination of manganese distribution in the brain. Acta Neuropathol (1986) 1.52
Occupational exposure to welding fume among welders: alterations of manganese, iron, zinc, copper, and lead in body fluids and the oxidative stress status. J Occup Environ Med (2004) 1.52
Brain magnetic resonance imaging and manganese concentrations in red blood cells of smelting workers: search for biomarkers of manganese exposure. Neurotoxicology (2006) 1.52
Human blood-brain barrier transferrin receptor. Metabolism (1987) 1.50
Iron interactions and other biological reactions mediating the physiological and toxic actions of manganese. Biochem Pharmacol (2003) 1.48
Effective treatment of manganese-induced occupational Parkinsonism with p-aminosalicylic acid: a case of 17-year follow-up study. J Occup Environ Med (2006) 1.38
Hepatic encephalopathy: An update of pathophysiologic mechanisms. Proc Soc Exp Biol Med (1999) 1.36
Transferrin receptors in rat brain: neuropeptide-like pattern and relationship to iron distribution. Proc Natl Acad Sci U S A (1985) 1.35
The diagnosis of manganese-induced parkinsonism. Neurotoxicology (2005) 1.33
Neurobehavioral evaluation of rhesus monkey infants fed cow's milk formula, soy formula, or soy formula with added manganese. Neurotoxicol Teratol (2005) 1.33
Increase in signal intensities on T1-weighted magnetic resonance images in asymptomatic manganese-exposed workers. Neurotoxicology (1999) 1.31
Manganese poisoning and the attack of trivalent manganese upon catecholamines. Arch Biochem Biophys (1987) 1.29
Effects of chronic manganese exposure on cognitive and motor functioning in non-human primates. Brain Res (2006) 1.27
Axonal transport of manganese and its relevance to selective neurotoxicity in the rat basal ganglia. Brain Res (1994) 1.26
Effects of manganese oxide on monkeys as revealed by a combined neurochemical, histological and neurophysiological evaluation. Arch Toxicol (1987) 1.26
Comparative toxicokinetics of manganese chloride and methylcyclopentadienyl manganese tricarbonyl (MMT) in Sprague-Dawley rats. Toxicol Sci (2000) 1.25
Manganese (Mn) transport across the rat blood-brain barrier: saturable and transferrin-dependent transport mechanisms. Brain Res Bull (1994) 1.25
Chronic manganese poisoning. Clearance of tissue manganese concentrations with persistance of the neurological picture. Neurology (1968) 1.25
Rapid brain uptake of manganese(II) across the blood-brain barrier. J Neurochem (1993) 1.25
Alteration of serum concentrations of manganese, iron, ferritin, and transferrin receptor following exposure to welding fumes among career welders. Neurotoxicology (2005) 1.24
Neurobehavioral effects of manganese in workers from a ferroalloy plant after temporary cessation of exposure. Scand J Work Environ Health (1995) 1.23
Modification of chronic manganese poisoning. Treatment with L-dopa or 5-OH tryptophane. N Engl J Med (1970) 1.23
Manganese accumulates in iron-deficient rat brain regions in a heterogeneous fashion and is associated with neurochemical alterations. Biol Trace Elem Res (2002) 1.23
Interactions between excessive manganese exposures and dietary iron-deficiency in neurodegeneration. Environ Toxicol Pharmacol (2005) 1.22
Chronic manganese intoxication. Arch Neurol (1989) 1.22
Manganese metabolism is impaired in the Belgrade laboratory rat. J Comp Physiol B (1997) 1.21
Iron overload following manganese exposure in cultured neuronal, but not neuroglial cells. Brain Res (2001) 1.21
Manganese neurotoxicity and glutamate-GABA interaction. Neurochem Int (2003) 1.20
Drug "diffusion" within the brain. Ann N Y Acad Sci (1988) 1.19
Effects of iron deficiency and iron overload on manganese uptake and deposition in the brain and other organs of the rat. Biol Trace Elem Res (1997) 1.18
Role of manganese in dystonia. Adv Neurol (1976) 1.18
Manganese intoxication and chronic liver failure. Ann Neurol (1994) 1.18
Alteration at translational but not transcriptional level of transferrin receptor expression following manganese exposure at the blood-CSF barrier in vitro. Toxicol Appl Pharmacol (2005) 1.17
Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic parkinsonism. Ann Neurol (1994) 1.17
Progression after chronic manganese exposure. Neurology (1993) 1.16
Results of magnetic resonance imaging in long-term manganese dioxide-exposed workers. Environ Res (2001) 1.16
The possible role of iron in the etiopathology of Parkinson's disease. Mov Disord (1993) 1.15
Manganese toxicity in children receiving long-term parenteral nutrition. Lancet (1996) 1.13
Distribution of iron in the basal ganglia and neocortex in postmortem tissue in Parkinson's disease and Alzheimer's disease. Dementia (1993) 1.12
Manganese distribution across the blood-brain barrier. I. Evidence for carrier-mediated influx of managanese citrate as well as manganese and manganese transferrin. Neurotoxicology (2003) 1.11
[18F]FDOPA PET and clinical features in parkinsonism due to manganism. Mov Disord (2005) 1.11
Idiopathic parkinsonism with superimposed manganese exposure: utility of positron emission tomography. Neurotoxicology (1999) 1.10
The chromium, manganese, and cobalt complexes of transferrin. J Biol Chem (1969) 1.10
Long-term progression in chronic manganism: ten years of follow-up. Neurology (1998) 1.09
Existing and emerging mechanisms for transport of iron and manganese to the brain. J Neurosci Res (1999) 1.08
Saturable transport of manganese(II) across the rat blood-brain barrier. J Neurochem (1991) 1.08
Manganese-induced cytotoxicity in dopamine-producing cells. Neurotoxicology (2004) 1.08
Neuropsychological sequelae of exposure to welding fumes in a group of occupationally exposed men. Int J Hyg Environ Health (2003) 1.07
Examination of blood-brain barrier permeability in dementia of the Alzheimer type with [68Ga]EDTA and positron emission tomography. J Cereb Blood Flow Metab (1987) 1.07
Dopamine transporter density is decreased in parkinsonian patients with a history of manganese exposure: what does it mean? Mov Disord (2002) 1.06
SLC11 family of H+-coupled metal-ion transporters NRAMP1 and DMT1. Pflugers Arch (2003) 1.06
Progression of dopaminergic degeneration in Parkinson's disease and atypical parkinsonism: a longitudinal beta-CIT SPECT study. Mov Disord (2002) 1.06
Manganese intoxication during total parenteral nutrition: report of two cases and review of the literature. J Neurol Sci (1999) 1.06
Manganese transport across the blood-brain barrier: relationship to iron homeostasis. Brain Res Bull (1990) 1.05
Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries. Proc Natl Acad Sci U S A (2006) 9.92
Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet (2013) 8.24
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet (2013) 5.58
Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci (2006) 5.15
Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet (2009) 5.14
A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet (2010) 4.89
Influence of exercise, walking, cycling, and overall nonexercise physical activity on mortality in Chinese women. Am J Epidemiol (2007) 4.63
High-throughput screening assays for the identification of chemical probes. Nat Chem Biol (2007) 4.50
Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians. Nat Genet (2011) 4.50
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet (2016) 4.49
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
A novel ALK secondary mutation and EGFR signaling cause resistance to ALK kinase inhibitors. Cancer Res (2011) 4.22
Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet (2014) 4.13
Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet (2013) 3.81
Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. Am J Physiol Endocrinol Metab (2004) 3.75
Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69
Southern community cohort study: establishing a cohort to investigate health disparities. J Natl Med Assoc (2005) 3.67
A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet (2010) 3.53
Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol (2010) 3.51
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet (2013) 3.42
A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat Genet (2011) 3.37
Lead neurotoxicity in children: basic mechanisms and clinical correlates. Brain (2003) 3.23
The neuroblastoma-associated F1174L ALK mutation causes resistance to an ALK kinase inhibitor in ALK-translocated cancers. Cancer Res (2010) 3.16
Soy food intake and breast cancer survival. JAMA (2009) 3.16
The landscape of recombination in African Americans. Nature (2011) 3.06
Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice. Cardiovasc Res (2008) 2.97
Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence. Lancet Oncol (2011) 2.85
Abdominal adiposity and mortality in Chinese women. Arch Intern Med (2007) 2.75
Application of real-time cell electronic sensing (RT-CES) technology to cell-based assays. Assay Drug Dev Technol (2004) 2.74
Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol (2004) 2.73
Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome. Proc Natl Acad Sci U S A (2005) 2.72
Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes. Mol Cancer Ther (2007) 2.71
Meta-analysis identifies common variants associated with body mass index in east Asians. Nat Genet (2012) 2.70
Effects of reproductive and demographic changes on breast cancer incidence in China: a modeling analysis. J Natl Cancer Inst (2008) 2.69
Identification of new genetic risk variants for type 2 diabetes. PLoS Genet (2010) 2.62
1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. J Biol Chem (2007) 2.61
Manganese toxicity upon overexposure. NMR Biomed (2004) 2.61
Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. Gastroenterology (2012) 2.57
Night-shift work and breast cancer risk in a cohort of Chinese women. Am J Epidemiol (2010) 2.48
Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair. Pharmacol Ther (2008) 2.47
A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum Mol Genet (2012) 2.45
Dietary patterns and their correlates among middle-aged and elderly Chinese men: a report from the Shanghai Men's Health Study. Br J Nutr (2007) 2.35
Association of leukocyte telomere length with breast cancer risk: nested case-control findings from the Shanghai Women's Health Study. Am J Epidemiol (2013) 2.34
Chemical calcium indicators. Methods (2008) 2.33
Prospective study of dietary carbohydrates, glycemic index, glycemic load, and incidence of type 2 diabetes mellitus in middle-aged Chinese women. Arch Intern Med (2007) 2.31
The analysis of large-scale gene expression correlated to the phase changes of the migratory locust. Proc Natl Acad Sci U S A (2004) 2.26
Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia. Nat Genet (2012) 2.26
Validity and reproducibility of the food-frequency questionnaire used in the Shanghai men's health study. Br J Nutr (2007) 2.26
Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers. Am J Hum Genet (2013) 2.24
dmGWAS: dense module searching for genome-wide association studies in protein-protein interaction networks. Bioinformatics (2010) 2.23
Compound Management for Quantitative High-Throughput Screening. JALA Charlottesv Va (2008) 2.11
VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling. Nat Cell Biol (2011) 2.09
A meta-analysis of bisphosphonates for periprosthetic bone loss after total joint arthroplasty. J Orthop Sci (2013) 2.09
Vanadium exposure-induced neurobehavioral alterations among Chinese workers. Neurotoxicology (2013) 2.08
Ovariectomy augments hypertension in aging female Dahl salt-sensitive rats. Hypertension (2004) 2.05
An automated, broad-based, near real-time public health surveillance system using presentations to hospital Emergency Departments in New South Wales, Australia. BMC Public Health (2005) 1.99
Identification of a functional genetic variant at 16q12.1 for breast cancer risk: results from the Asia Breast Cancer Consortium. PLoS Genet (2010) 1.98
Elevated blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations in essential tremor. Neurotoxicology (2007) 1.98
The choroid plexus removes beta-amyloid from brain cerebrospinal fluid. Exp Biol Med (Maywood) (2005) 1.97
Genome-wide association study of glioma and meta-analysis. Hum Genet (2012) 1.96
Circulating 25-hydroxyvitamin D and the risk of rarer cancers: Design and methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol (2010) 1.95
Reproducibility and validity of the Shanghai Women's Health Study physical activity questionnaire. Am J Epidemiol (2003) 1.95
Enhanced statistical tests for GWAS in admixed populations: assessment using African Americans from CARe and a Breast Cancer Consortium. PLoS Genet (2011) 1.94
Genome-wide association study in east Asians identifies novel susceptibility loci for breast cancer. PLoS Genet (2012) 1.91
Common variants at CDKAL1 and KLF9 are associated with body mass index in east Asian populations. Nat Genet (2012) 1.90
Correlates of circulating 25-hydroxyvitamin D: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol (2010) 1.90
A robotic platform for quantitative high-throughput screening. Assay Drug Dev Technol (2008) 1.90
The 5p15.33 locus is associated with risk of lung adenocarcinoma in never-smoking females in Asia. PLoS Genet (2010) 1.90
Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Arch Intern Med (2010) 1.88
Legume and soy food intake and the incidence of type 2 diabetes in the Shanghai Women's Health Study. Am J Clin Nutr (2008) 1.87
Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Am J Epidemiol (2009) 1.87
Evaluation of breast cancer susceptibility loci in Chinese women. Cancer Epidemiol Biomarkers Prev (2010) 1.87
Associations of body mass index, smoking, and alcohol consumption with prostate cancer mortality in the Asia Cohort Consortium. Am J Epidemiol (2015) 1.87
Genome-wide association analyses in East Asians identify new susceptibility loci for colorectal cancer. Nat Genet (2012) 1.85
Genome-wide association study identifies a common variant associated with risk of endometrial cancer. Nat Genet (2011) 1.84
Fine mapping of chromosome 6q23-25 region in familial lung cancer families reveals RGS17 as a likely candidate gene. Clin Cancer Res (2009) 1.83
Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium. Cancer Res (2010) 1.82
A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet (2013) 1.82
Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4. Nat Genet (2012) 1.78
Intra-individual variation of plasma adipokine levels and utility of single measurement of these biomarkers in population-based studies. Cancer Epidemiol Biomarkers Prev (2007) 1.77
Use of complementary and alternative medicine by chinese women with breast cancer. Breast Cancer Res Treat (2004) 1.76
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat Commun (2013) 1.73
Exome sequencing generates high quality data in non-target regions. BMC Genomics (2012) 1.72
Combined impact of lifestyle-related factors on total and cause-specific mortality among Chinese women: prospective cohort study. PLoS Med (2010) 1.71
Association of cyclin D1 genotype with breast cancer risk and survival. Cancer Epidemiol Biomarkers Prev (2005) 1.69
Lead neurotoxicity: from exposure to molecular effects. Brain Res Brain Res Rev (2005) 1.69
Modeling supravalvular aortic stenosis syndrome with human induced pluripotent stem cells. Circulation (2012) 1.69
Genome-wide association study of survival in patients with pancreatic adenocarcinoma. Gut (2012) 1.66
Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma. Nat Genet (2012) 1.64
Female protection in progressive renal disease is associated with estradiol attenuation of superoxide production. Gend Med (2007) 1.63
Prospective study of urinary prostaglandin E2 metabolite and colorectal cancer risk. J Clin Oncol (2006) 1.62
Genetic polymorphisms in the estrogen receptor alpha gene and risk of breast cancer: results from the Shanghai Breast Cancer Study. Cancer Epidemiol Biomarkers Prev (2003) 1.62
Aurora-A/STK15 T+91A is a general low penetrance cancer susceptibility gene: a meta-analysis of multiple cancer types. Carcinogenesis (2005) 1.61
Meat intake and cause-specific mortality: a pooled analysis of Asian prospective cohort studies. Am J Clin Nutr (2013) 1.61
Small-molecule agonists for the thyrotropin receptor stimulate thyroid function in human thyrocytes and mice. Proc Natl Acad Sci U S A (2009) 1.61
Urinary isothiocyanate levels, brassica, and human breast cancer. Cancer Res (2003) 1.60
Evaluating cost efficiency of SNP chips in genome-wide association studies. Genet Epidemiol (2008) 1.60
Obesity and weight change in relation to breast cancer survival. Breast Cancer Res Treat (2010) 1.60
A large population of 'Lyman-break' galaxies in a protocluster at redshift z approximately 4.1. Nature (2004) 1.59